MDGL

Madrigal Pharmaceuticals, Inc. Common Stock

$135.11 +$1.76 +1.30%



Shares Bought4
Shares Sold4
Total8
Shares Owned0
Last Price$135.11
Total Return$16.42
Range Today$132.05 - $135.98
52 Week Range$13.09 - $154.75
Open$133.34
Market Cap$1.69B
Volume/Average76.57K/96.64K
P/E Ratio-
Dividend/Yield0.00




Madrigal Pharmaceuticals, Inc. clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel compounds for the treatment of cardiovascular, metabolic and liver diseases. The company offers MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Madrigal Pharmaceuticals was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.


Wallet Positions

Buy Date Buy Price Quote Return $ Return % Owners

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
17-09-22 20:50 17-09-26 19:15 $34.18 $33.54 -$0.64 -1.87% manthello genovahero
18-01-26 16:59 18-01-29 15:03 $119.51 $127.63 +$8.12 +6.79% hoyaow funkmasterflexion tukwada krakenjaws cypc
18-01-26 16:58 18-01-29 15:02 $120.30 $127.61 +$7.31 +6.08% funkmasterflexion michrob krakenjaws
17-09-22 13:54 17-09-22 14:42 $27.98 $29.61 +$1.63 +5.83% sohardtokill1